Hemab Therapeutics Holdings, Inc. Common Stock (COAG NASDAQ) stock market data APIs
$44.9334
-0.73(-1.6%)
as of September 8, 2026
Try our APIs with
free plan!
Hemab Therapeutics Holdings, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts.
Prev. Close
44.9334
Open
44.2041
High
45.3457
Low
43.051
52 wk Range
18-55.42
Market Cap
2 082 M
Shares Outstanding
46 712 K
EPS
-0.8
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Hemab Therapeutics Holdings, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hemab Therapeutics Holdings, Inc. Common Stock data using free add-ons & libraries
Get Hemab Therapeutics Holdings, Inc. Common Stock Fundamental Data
Hemab Therapeutics Holdings, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -86 893 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Hemab Therapeutics Holdings, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-11
- EPS/Forecast: -0.63
Get Hemab Therapeutics Holdings, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hemab Therapeutics Holdings, Inc. Common Stock News
New
Biotech Stocks At 52-Week Highs - DCTH +22% On Q2 Results, ANRO, COAG, MNPR, NRIX
(RTTNews) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming conference participation. Delcath Systems Inc....
Biotech IPO Gains Crush AI Listings With Standout 55% Return
(Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer de...
Biotech Stocks At 52-Week Highs - XNCR, COAG, MNPR, SOPH, ACRS
(RTTNews) - The following biotech stocks reached a 52-week high on July 20, 2026, driven by key catalysts such as upcoming clinical trial launches and the prospective release of data from these studie...
Hemab Presents Sutacimig Data; Wedbush Rates Outperform, $55 Target
(RTTNews) - Hemab Therapeutics (COAG) presented new clinical and preclinical data for its lead candidate Sutacimig at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Pa...
Get Hemab Therapeutics Holdings, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
